Giuseppe Belmonte Selected Research

Giuseppe Belmonte Research Topics

Disease

5	Rett Syndrome (Rett's Disorder) 10/2014 - 07/2013
4	Neoplasms (Cancer) 01/2021 - 12/2014
4	Wounds and Injuries (Trauma) 01/2018 - 01/2011
3	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 01/2015
3	Melanoma (Melanoma, Malignant) 01/2020 - 12/2014
3	Endometriosis 04/2018 - 05/2014
3	Autistic Disorder (Autism) 01/2016 - 01/2013
3	Neurodevelopmental Disorders 10/2014 - 01/2014
2	Infertility (Sterility) 10/2019 - 02/2015
2	Globoid Cell Leukodystrophy (Krabbe Disease) 04/2017 - 02/2015
2	Inflammation (Inflammations) 01/2015 - 05/2013
2	Skin Diseases (Skin Disease) 01/2012 - 09/2010
1	Male Infertility (Male Sterility) 01/2022
1	Leiomyoma (Uterine Fibroids) 11/2021
1	Aneuploidy (Aneuploid) 05/2021
1	Nervous System Diseases (Neurological Disorders) 04/2021
1	Hypertrophy 04/2021
1	Astrocytoma (Pilocytic Astrocytoma) 04/2021
1	Retinoblastoma (Glioblastoma, Retinal) 01/2021
1	Gliosis 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Teratozoospermia 10/2019
1	Asthenozoospermia 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Osteoarthritis 01/2017
1	Acne Vulgaris 01/2017
1	Dermatitis 01/2017
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Infections 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2015
1	CDKL5 deficiency disorder 09/2015
1	Carcinogenesis 12/2014
1	Obesity 02/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2013
1	Inclusion Body Myositis 01/2013
1	Autism Spectrum Disorder 01/2013
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
4	CytokinesIBA 04/2021 - 02/2014
4	Methyl-CpG-Binding Protein 2IBA 10/2014 - 01/2014
3	Cyclin D1IBA 01/2020 - 01/2011
3	Scavenger Receptors (Scavenger Receptor)IBA 01/2018 - 07/2013
3	Beclin-1IBA 08/2016 - 12/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2016
2	GalactosylceramidaseIBA 04/2017 - 02/2015
2	EnzymesIBA 04/2017 - 02/2015
2	SmokeIBA 01/2017 - 09/2010
2	Messenger RNA (mRNA)IBA 02/2016 - 05/2014
2	LipidsIBA 09/2015 - 01/2012
2	high density lipoprotein receptorsIBA 10/2014 - 07/2013
2	Vascular Endothelial Growth FactorsIBA 01/2013 - 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 11/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 05/2021
1	Glial Fibrillary Acidic ProteinIBA 04/2021
1	Interleukin-4 (Interleukin 4)IBA 04/2021
1	Interleukin-10 (Interleukin 10)IBA 04/2021
1	CalciumIBA 04/2021
1	LigandsIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Everolimus FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Particulate MatterIBA 01/2018
1	GlycolipidsIBA 04/2017
1	Glycerol (Glycerine)FDA LinkGeneric 04/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	OzoneIBA 09/2016
1	Temozolomide (Temodar)FDA LinkGeneric 08/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2016
1	SynaptophysinIBA 02/2016
1	Nerve Growth Factor (NGF)IBA 02/2016
1	N 30IBA 02/2016
1	ChemokinesIBA 01/2016
1	TubulinIBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2015
1	GD 7IBA 09/2015
1	Bromodeoxyuridine (BrdU)IBA 09/2015
1	Galactosylceramides (Galactocerebrosides)IBA 02/2015
1	SphingolipidsIBA 02/2015
1	Psychosine (Galactosylsphingosine)IBA 02/2015
1	FSH Receptors (FSH Receptor)IBA 02/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	NF-kappa B (NF-kB)IBA 01/2015
1	anti-Mullerian hormone receptorIBA 05/2014
1	Hormones (Hormone)IBA 05/2014
1	Triglycerides (Triacylglycerol)IBA 02/2014
1	oxidized low density lipoproteinIBA 02/2014
1	HDL LipoproteinsIBA 02/2014
1	CholesterolIBA 02/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2014
1	Actins (F Actin)IBA 01/2014
1	VA428IBA 05/2013
1	2- methyl- 5- (4- methylsulphonyl)phenyl- 1- phenyl- 3- (2- n- propyloxyethyl)- 1H- pyrroleIBA 05/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 08/2016
2	Radiotherapy 08/2016 - 01/2015